ANTIANDROGEN, VACCINE AND COMBINATION THERAPY IN PATIENTS WITH NONMETASTATIC HORMONE REFRACTORY PROSTATE CANCER

DOI Web Site Web Site Web Site 1 Citations
  • PHILIP M. ARLEN
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • JAMES L. GULLEY
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • NUSHIN TODD
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • RONALD LIEBERMAN
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • SETH M. STEINBERG
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • STEVE MORIN
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • ANNE BASTIAN
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • JENNIFER MARTE
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • KWONG-YOK TSANG
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • PATRICIA BEETHAM
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • DOUGLAS W. GROSENBACH
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • JEFFREY SCHLOM
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • WILLIAM DAHUT
    Laboratory of Tumor Immunology and Biology, Center for Cancer Research (PMA, JLG, NT, SM, JM, K-YT, PM, DWG, JS), Division of Cancer Prevention (RL), Biostatistics and Data Management Section, Center for Cancer Research (SMS), Medical Oncology Clinical Research Unit, Center for Cancer Research (AB, WD), National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Journal

  • Journal of Urology

    Journal of Urology 174 (2), 539-546, 2005-08

    Ovid Technologies (Wolters Kluwer Health)

Citations (1)*help

See more

Report a problem

Back to top